| Q34638914 | 12th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: susceptibility to environmental hazards |
| Q43007591 | A mutation in exon 7 of the human cytochrome P-4501A1 gene as marker for sensitivity to anti-cancer drugs? |
| Q45712914 | A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk |
| Q28210138 | A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma |
| Q36463097 | A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview |
| Q53766455 | An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. |
| Q33781327 | An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium |
| Q73213088 | An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers |
| Q86034442 | Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis |
| Q43727711 | Association between genetic polymorphisms and biomarkers in styrene-exposed workers |
| Q35938660 | Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer |
| Q40848904 | Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer |
| Q53289726 | Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population. |
| Q35237947 | Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population |
| Q36641296 | Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma |
| Q37041236 | Association of Functional Variants of Phase I and II Genes with Chronic Obstructive Pulmonary Disease in a Serbian Population |
| Q36353114 | Association of Polymorphisms of Phase I Metabolizing Genes with Sister Chromatid Exchanges in Occupational Workers Exposed to Toluene Used in Paint Thinners |
| Q42698458 | Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease |
| Q89621705 | Association of the G134A and G184C Polymorphisms in the CYP1A1 Gene with Lung Cancer Incidence |
| Q73204406 | Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma |
| Q64074658 | Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis |
| Q72095918 | B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu) |
| Q33842950 | Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis |
| Q34761410 | Biomonitoring of tobacco smoke carcinogenicity by dosimetry of DNA adducts and genotyping and phenotyping of biotransformational enzymes: a review on polycyclic aromatic hydrocarbons |
| Q73040205 | Biphasic kinetic behavior of rat cytochrome P-4501A1-dependent monooxygenation in recombinant yeast microsomes |
| Q36970401 | CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. |
| Q53411594 | CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. |
| Q38504466 | CYP1A1 and GSTM1/T1 genetic variation in predicting risk for cerebral infarction |
| Q82222899 | CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer |
| Q33944732 | CYP1A1 gene polymorphisms as a risk factor for pterygium |
| Q36145974 | CYP1A1 protein activity is associated with allelic variation in pterygium tissues and cells. |
| Q45033892 | CYP1A1, GSTM1 and GSTT1 genetic polymorphism is associated with susceptibility to polycystic ovaries in South Indian women |
| Q37111248 | CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study |
| Q28207134 | CYP1B1 gene in endometrial cancer |
| Q34459045 | Candidate gene case-control association studies: advantages and potential pitfalls |
| Q35073279 | Candidate gene case-control studies. |
| Q36768186 | Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes |
| Q33236016 | Challenges identifying genetic determinants of pediatric cancers--the childhood leukemia experience |
| Q24806426 | Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women |
| Q42053574 | Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system |
| Q41561476 | Combinations of susceptible genotypes and individual responses to toxicants |
| Q46896451 | Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects |
| Q73798162 | Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma |
| Q33468680 | Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention |
| Q36620550 | Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan |
| Q74015429 | DNA adduct level in lung tissue may act as a risk biomarker of lung cancer |
| Q43948390 | DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic |
| Q44075525 | Detection of CYP I A1 polymorphisms with a colorimetric method based on mismatch hybridization |
| Q58454750 | Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese |
| Q33826374 | Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy |
| Q47129139 | Development of diagnostic model of lung cancer based on multiple tumor markers and data mining |
| Q40442625 | Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review |
| Q33700123 | Drug interactions with tobacco smoking. An update |
| Q33650419 | Drug metabolism polymorphisms as modulators of cancer susceptibility. |
| Q54011162 | Effect of genotype on steady-state CYP1A1 gene expression in human peripheral lymphocytes. |
| Q44428671 | Effects of dietary habits and CYP1A1 polymorphisms on blood dioxin concentrations in Japanese men. |
| Q33605331 | Environmental factors as regulators and effectors of multistep carcinogenesis |
| Q35972488 | Estrogen-related genes and their contribution to racial differences in breast cancer risk |
| Q78148735 | Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations |
| Q34714582 | Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection |
| Q43652344 | Gender difference in DNA adduct levels among nonsmoking lung cancer patients |
| Q34460648 | Gene mutation as a target for early detection in cancer diagnosis. |
| Q38556530 | Gene-environment interactions in esophageal cancer |
| Q24679438 | Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility |
| Q40735434 | Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A. |
| Q71690062 | Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease |
| Q33639778 | Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues |
| Q43743146 | Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer |
| Q50981496 | Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. |
| Q34638744 | Genetic polymorphism of cytochrome P450 as a biomarker of susceptibility to environmental toxicity |
| Q53418320 | Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. |
| Q37296120 | Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer |
| Q34582043 | Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility |
| Q44781170 | Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. |
| Q34421971 | Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias |
| Q44124790 | Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer |
| Q46521553 | Genetic polymorphisms in the cytochromes P-450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children |
| Q43733516 | Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China |
| Q33538523 | Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity |
| Q43893026 | Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. |
| Q43913314 | Genetic susceptibility of term pregnant women to oxidative damage |
| Q34011524 | Genetic susceptibility to childhood acute lymphoblastic leukemia. |
| Q35868053 | Genetic susceptibility to tobacco-related cancer |
| Q53410257 | Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. |
| Q44934775 | Genotype and phenotype of glutathione-S-transferase in patients with head and neck carcinoma |
| Q41828306 | Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. |
| Q77575324 | Genotyping metabolic polymorphisms in a cohort of Caucasians and single strand conformation polymorphism analysis of point mutations in human hprt exons 7 and 8 |
| Q73722106 | Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking |
| Q37434637 | Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene |
| Q54985963 | High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes |
| Q40654815 | Human CYP1A1 allelic variants: baculovirus expression and purification, hydrodynamic, spectral, and catalytical properties and their potency in the formation of all-trans-retinoic acid |
| Q71497777 | Identification of allelic variants of the human CYP1A1 gene |
| Q46525258 | Impact of Cyp1A1 and Comt Genotypes on Breast Cancer Risk in Mexican Women: A Pilot Study |
| Q35491910 | Influence of genetic susceptibility on the urinary excretion of 8-hydroxydeoxyguanosine of firefighters |
| Q41561466 | Interaction between dose and susceptibility to environmental cancer: a short review |
| Q42611138 | Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1B1 in inhibiting catalytic activity |
| Q73355689 | Investigation of mutant frequency at the HPRT locus and changes in microsatellite sequences in healthy young adults |
| Q43813775 | Low-penetrance genes are associated with increased susceptibility to endometriosis |
| Q37856965 | Lung cancer andCYP1A1 orGSTM1 polymorphisms |
| Q46246677 | Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking |
| Q36464478 | Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming |
| Q33678877 | Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review |
| Q84395473 | Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking |
| Q35561167 | Modulating influence of cytochrome P-450 MspI polymorphism on serum liver function profiles in coke oven workers |
| Q77120178 | Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms |
| Q41073233 | Molecular basis of polymorphic drug metabolism |
| Q33646220 | Molecular epidemiologic research on the effects of environmental pollutants on the fetus |
| Q33643298 | Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer |
| Q28293994 | Molecular genetics of the human cytochrome P450 monooxygenase superfamily |
| Q33951229 | Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer |
| Q35587961 | Mutational analysis of xenobiotic metabolizing genes (CYP1A1 and GSTP1) in sporadic head and neck cancer patients |
| Q36929920 | P450 and Human Cancer |
| Q24812002 | Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome |
| Q33781271 | Pharmacogenetics of cytochromes P450. |
| Q28767825 | Pharmacogenetics: detecting sensitive populations |
| Q60446461 | Polimorfismos dos alelos m1 e m2 do gene CYP1A1: Susceptibilidade genética para o cancro do pulmão |
| Q42752160 | Polymorphism in CYP1A1, GSTMI, GSTT1 genes and organochlorine pesticides in the etiology of hypospadias |
| Q44097248 | Polymorphism of metabolic genes and susceptibility to occupational chronic manganism |
| Q35587973 | Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: Application of the additive model for cancer. |
| Q44325849 | Polymorphisms in steroid hormone pathway genes and mammographic density |
| Q53018632 | Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'-flanking region. |
| Q37065569 | Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer |
| Q73457793 | Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2 |
| Q44168604 | Polymorphisms of CYP1a1, CYP2e1, GSTM1, GSTT1, and TP53 genes in Amerindians |
| Q43640219 | Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population |
| Q33608783 | Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer |
| Q44303113 | Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population |
| Q40498843 | Possible role of cytochromes P450 in lupus erythematosus and related disorders. |
| Q28245203 | Recalling P446. P4501A1 (CYP1A1) opting for clinical application |
| Q53435198 | Regio- and stereoselectivity in the metabolism of benzo[c]phenanthrene mediated by genetically engineered V79 Chinese hamster cells expressing rat and human cytochromes P450. |
| Q34937869 | Relationship between ambient air pollution and DNA damage in Polish mothers and newborns |
| Q51370330 | Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population. |
| Q83333982 | Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes |
| Q36469802 | Single nucleotide polymorphisms: early diagnosis and risk assessment in genitourinary malignancy |
| Q33890709 | Smoking and the molecular epidemiology of lung cancer |
| Q54408491 | Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer |
| Q77190382 | Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases |
| Q36431685 | Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci |
| Q43891845 | The effect of relevant genotypes on PAH exposure-related biomarkers |
| Q41570913 | The molecular epidemiology of lung cancer |
| Q28276614 | The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene |
| Q34636999 | The role of individual susceptibility in cancer burden related to environmental exposure |
| Q33534063 | Use of biomarkers--new frontiers in occupational toxicology and epidemiology |
| Q34833677 | Using biomarkers of genetic susceptibility to enhance the study of cancer etiology |
| Q34054703 | Xenobiotic metabolism, genetic polymorphisms and male infertility |